Navamedic ASA (NAVA) - Total Liabilities
Based on the latest financial reports, Navamedic ASA (NAVA) has total liabilities worth Nkr407.67 Million NOK (≈ $42.90 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore NAVA cash flow conversion to assess how effectively this company generates cash.
Navamedic ASA - Total Liabilities Trend (2003–2025)
This chart illustrates how Navamedic ASA's total liabilities have evolved over time, based on quarterly financial data. Check how resilient are Navamedic ASA's assets to evaluate the company's liquid asset resilience ratio.
Navamedic ASA Competitors by Total Liabilities
The table below lists competitors of Navamedic ASA ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Australian Vanadium Ltd
AU:AVL
|
Australia | AU$13.62 Million |
|
Fractal Gaming Group AB
ST:FRACTL
|
Sweden | Skr230.10 Million |
|
Pan Brothers Tbk
JK:PBRX
|
Indonesia | Rp130.50 Million |
|
Vection Technologies Ltd
AU:VR1
|
Australia | AU$59.39 Million |
|
Union Corporation
KO:000910
|
Korea | ₩212.48 Billion |
|
Mawana Sugars Limited
NSE:MAWANASUG
|
India | Rs1.08 Billion |
|
Francotyp-Postalia Holding AG
F:FPH
|
Germany | €113.20 Million |
|
Victory Square Technologies Inc
F:6F6
|
Germany | €8.17 Million |
Liability Composition Analysis (2003–2025)
This chart breaks down Navamedic ASA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Navamedic ASA market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.55 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.42 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.22 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.55 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Navamedic ASA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Navamedic ASA (2003–2025)
The table below shows the annual total liabilities of Navamedic ASA from 2003 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | Nkr407.67 Million ≈ $42.90 Million |
+62.55% |
| 2024-12-31 | Nkr250.81 Million ≈ $26.39 Million |
-16.93% |
| 2023-12-31 | Nkr301.91 Million ≈ $31.77 Million |
+74.46% |
| 2022-12-31 | Nkr173.05 Million ≈ $18.21 Million |
-3.29% |
| 2021-12-31 | Nkr178.94 Million ≈ $18.83 Million |
+37.07% |
| 2020-12-31 | Nkr130.55 Million ≈ $13.74 Million |
+21.08% |
| 2019-12-31 | Nkr107.83 Million ≈ $11.35 Million |
-6.57% |
| 2018-12-31 | Nkr115.41 Million ≈ $12.14 Million |
-23.35% |
| 2017-12-31 | Nkr150.57 Million ≈ $15.84 Million |
-17.24% |
| 2016-12-31 | Nkr181.94 Million ≈ $19.15 Million |
+15.68% |
| 2015-12-31 | Nkr157.27 Million ≈ $16.55 Million |
+54.23% |
| 2014-12-31 | Nkr101.97 Million ≈ $10.73 Million |
+41.19% |
| 2013-12-31 | Nkr72.22 Million ≈ $7.60 Million |
+94.80% |
| 2012-12-31 | Nkr37.07 Million ≈ $3.90 Million |
-19.11% |
| 2011-12-31 | Nkr45.83 Million ≈ $4.82 Million |
+98.24% |
| 2010-12-31 | Nkr23.12 Million ≈ $2.43 Million |
-6.65% |
| 2009-12-31 | Nkr24.77 Million ≈ $2.61 Million |
-49.86% |
| 2008-12-31 | Nkr49.40 Million ≈ $5.20 Million |
-12.51% |
| 2007-12-31 | Nkr56.46 Million ≈ $5.94 Million |
-768.93% |
| 2006-12-31 | Nkr-8.44 Million ≈ $-888.25K |
-275.64% |
| 2005-12-31 | Nkr4.81 Million ≈ $505.74K |
-347.21% |
| 2004-12-31 | Nkr-1.94 Million ≈ $-204.58K |
-69.81% |
| 2003-12-31 | Nkr-6.44 Million ≈ $-677.59K |
-- |
About Navamedic ASA
Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Norway, Sweden, Denmark, Finland, the Netherlands, and internationally. The company's product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. It offers medical nutritio… Read more